Update on primary ovarian insufficiency in adolescents

Curr Opin Pediatr. 2015 Aug;27(4):511-9. doi: 10.1097/MOP.0000000000000236.

Abstract

Purpose of review: We provide an overview of new insights into the genetic causes of primary ovarian insufficiency (POI) and address the challenges faced by clinicians who care for adolescents with this condition.

Recent findings: In most cases, the cause of POI remains a mystery after appropriate clinical testing has been completed. Large-scale genomic sequencing approaches are uncovering new mechanisms underlying the disorder. Gene variants that affect the normal processes of primordial germ-cell proliferation and migration, oocyte meiosis, and ovarian follicle formation/activation are plausible mechanisms. Whole exome sequencing has been used to associate many of these variants with human POI. POI is a serious chronic condition with no cure. It qualifies as a rare disease and as such presents special challenges to patients, parents, and clinicians. Although the diagnosis of POI is often delayed because of the assumption that irregular menses are common among adolescents, early detection is critical for the maintenance of bone and cardiovascular health. Treatment options have focused on hormonal therapy and fertility preservation. However, many studies prove the increasing need to incorporate mental health support and a family systems approach into the management plan.

Summary: Large-scale genomic sequencing has recently identified new mechanisms of POI. However, at present this testing is not clinically indicated as routine. Practice will change as genomic medicine is integrated into standard care. Adolescents with POI are best served by an integrated personal care approach centered on the patient and provided by a primary care clinician who has support from a multidisciplinary team.

Publication types

  • Research Support, N.I.H., Intramural
  • Review

MeSH terms

  • Adolescent
  • Amenorrhea / etiology*
  • Amenorrhea / psychology
  • Early Diagnosis
  • Estrogen Replacement Therapy / methods*
  • Female
  • Fertility Preservation / methods*
  • Fertility Preservation / psychology
  • Fragile X Mental Retardation Protein
  • Genetic Counseling
  • Humans
  • Infertility, Female / etiology*
  • Infertility, Female / psychology
  • Parents
  • Primary Ovarian Insufficiency / diagnosis*
  • Primary Ovarian Insufficiency / psychology
  • Primary Ovarian Insufficiency / therapy

Substances

  • FMR1 protein, human
  • Fragile X Mental Retardation Protein